How should we use transdermal fentanyl (TF) for pain management in palliative care patients?
Fainsinger
R L
RL
Palliative Care Program, Royal Alexandra Hospital, Edmonton, Alberta, Canada.
Bruera
E
E
D000279:Administration, Cutaneous; D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage* / Q000494:pharmacology; D002170:Canada; D002648:Child; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*; D010148:Intractable Pain / Q000188:drug therapy* / Q000209:etiology; D010166:Palliative Care
D000701:Analgesics, Opioid; D005283:Fentanyl